In addition, miR-30-5P inhibits the proliferation and migration of MM cells by targeting the 3’UTR of BCL9, a key coactivator of the Wnt/β-catenin signalling pathway, and downregulating the transcriptional activity of BCL9 and Wnt [106]. This evidence concerns the gene BCL9 and Miyoshi myopathy.